It's a very interesting situation to deal with. The lawyers must be salivating.
There have obviously been contraventions to the Corporations Code, and actions that would appear to have taken place, as related in the panel's findings, that suggest some may have been deliberate acts of concealment. Certainly with regards to the shares held by Rand, directors knew that the shares should have been sold but failed to do so even after their request for an extension was rejected. So my question is, if these contraventions occurred what other activities within the company have occurred to the detriment of most shareholders. The Board is famously secretive and there is no independent directors, so what has happened. I tried to find out how much gold the company had last year and I received a reply back from the Company Secretary saying the information was sensitive and they were not willing to release the information to shareholders......a gold company that wont tell it's shareholders how much gold it holds?????!!!!!
For Hedley to go after TBR I'm sure he has a game plan that will result in quite significant changes. The board obviously needs some independent representation so an ASIC appointed Chairperson would be be good if possible, plus another director
appointed by minority shareholders.....Then of course the forced sale of shares inappropriately held.
If you look into some past deals, there are some humdingers. I'd like to see some independent investigations.
Being the cynic that I am I'd also like to see the date of the board minute that approved the awarding of the dividend.
- Forums
- ASX - By Stock
- TBR
- Ann: TOV: TBR Declaration of Unacceptable Circumstances
Ann: TOV: TBR Declaration of Unacceptable Circumstances, page-57
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TBR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.93 |
Change
0.000(0.00%) |
Mkt cap ! $230.8M |
Open | High | Low | Value | Volume |
$5.00 | $5.00 | $4.93 | $8.398K | 1.69K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 462 | $4.93 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.00 | 4864 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1100 | 4.850 |
1 | 2079 | 4.800 |
2 | 2250 | 4.600 |
1 | 538 | 4.500 |
1 | 550 | 4.310 |
Price($) | Vol. | No. |
---|---|---|
4.960 | 1 | 1 |
4.970 | 2 | 1 |
5.120 | 1000 | 1 |
5.200 | 200 | 1 |
5.500 | 100 | 1 |
Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
Featured News
TBR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online